|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Health values of pa- tients with systemic sclerosis显示文摘 | Khanna D Ahmed M Furst D E | 2007 | Arthritis Rheum2007，57，1： | 1 |
| 2 | Internet banking 显示文摘 | Furst K Lang W W Nolle D E | 2002 | Journal of Financial Services Research2002，22，12： | 1 |
| 3 | Risk genotype in folate- dependent enzymes and their association with methotrexate-related side effects in rheumatoid arthritis 显示文摘 | Weisman M H Furst D E Park G S | 2006 | Arthritis Rheum2006，54，2： | 1 |
| 4 | Comparison and evaluation of methods for liver segmentation from CT datasets显示文摘 | Heimann T van Ginneken B Styner MA Arzhaeva Y Aurich V Bauer C Beck A Becket C Beichel R Bekes G Bello F Binnig G Bischof H Bornik A Cashman PM Chi Y Cordova A Dawant BM Fidrich M Furst JD Furukawa D Grenacher L Hornegger J Kainmuller D Kitney RI Kobatake H Lamecker H Lange T Lee J Lennon B Li R Li S Meinzer HP Nemeth G Raicu DS Rau AM van Rikxoort EM Rousson M Rusko L Saddi KA Schmidt G Seghers D Shimizu A Slagmolen P Sorantin E Soza G Susomboon R Waite JM Wimmer A Wolf I | 2009 | IEEE Transactions on Medical Imaging2009，28，8： | 1 |
| 5 | Correlation of the degree of dyspnea with health-related quality of life, function- al abilities, and diffusing capacity for carbon monoxide in pa- tients withsystemic sclerosis and active alveolitis:results from the scleroderma lung study显示文摘 | Khanna D Clements P J Furst D E | 2005 | Arthritis Rheum2005，52，2： | 1 |
| 6 | Risk genotype in folate-dependent enzymes and their association with methotrexate-related side effects in rheumatoid arthritis 显示文摘 | Weisman M H Furst D E Park G S | 2006 | Arthritis Rheum2006，54，2： | 1 |
| 7 | 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis显示文摘 | Singh J A Furst D E Bharat A | 2012 | Arthritis Care Res ( Hoboken)2012，64，5： | 1 |
| 8 | Rheumatoid arthritis pathophysiology: Update on emerging cytokine and cytokine-associated cell targets显示文摘 | FURST D E EMERY P | 2014 | Rheumatology(Oxford)2014，53，9： | 1 |
| 9 | Updated Consen- sus Statement on Biological Agents for the Treatment of Rheumatic Diseases,2011显示文摘 | Furst D E Keystone E C Braun J | 2012 | Ann Rheum Dis2012，71，12： | 1 |
| 10 | Gout and the risk of acute myocardial infarction显示文摘 | Krishnan E Baker J F Furst D E | 2006 | Arthritis and rheumatism2006，54，8： | 1 |
| 11 | Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis:ARMADA 4 year extended study显示文摘 | Keystone E C Furst D E | 2006 | Annals of the Rheumatic Diseases2006，65，： | 1 |
| 12 | High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel- group, dose-comparison colchicine study 显示文摘 | TERKELTAUB R A FURST D E BENNETT K | 2010 | Arthritis Rheum2010，62，4： | 1 |
| 13 | The risk of infections with biologic therapies for rheumatoid arthritis显示文摘 | Furst D E | 2010 | Semin Arthritis Rheum2010，39，32： | 1 |
| 14 | Microchimerism and HLA-compatible relationships of pregnancy in scleroderma 显示文摘 | Nelson J L Furst D E Maloney S | 1998 | Lancet1998，351，9102： | 1 |
| 15 | Updated con-sensus statement on biological agents for the treatment ofrheumatic diseases,2011 显示文摘 | FURST D E KEYSTONE E C BRAUN J | 2012 | Ann Rheum Dis2012，71，2： | 1 |
| 16 | Open - label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete re- sponse to etanereept :the opposite study显示文摘 | Furst D E Gaylis N Bray V | 2007 | Ann Rheum Dis2007，66，7： | 1 |
| 17 | Updated consensus statement on biological agents for the treatment of rheumatic diseases 显示文摘 | Furst D E Keystone E C Fleischmann R | 2010 | Ann Rheum Dis2010，69，： | 1 |
| 18 | Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012显示文摘 | Furst D E Keystone E C So A K | 2013 | Ann Rheum Dis2013，72，2： | 1 |
| 19 | Rheumatoid arthritis in the elderly:recent advances in understanding the pathogenesis, risk factors, comorbidities and risk- benefit of treatments 显示文摘 | Woodworth T Ranganath V Furst D E | 2013 | Aging Health2013，9，2： | 1 |
| 20 | The mode of my ofibril re- modelling in human skeletal muscle a fleeted by DOMS in- duced by eccentric contractions 显示文摘 | Yu J G Furst D O Thornell L E | 2003 | Histochem Cell Biol2003，119，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员